Mesna and Atrial fibrillation/flutter - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation/flutter is found among people who take Mesna, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Mesna and have Atrial fibrillation/flutter. It is created by eHealthMe based on reports of 8,290 people who have side effects when taking Mesna from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

8,290 people reported to have side effects when taking Mesna.
Among them, 133 people (1.6%) have Atrial fibrillation/flutter.

What is Mesna?

Mesna has active ingredients of mesna. eHealthMe is studying from 8,296 Mesna users for its effectiveness, alternative drugs and more.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 3,636 drugs and 3,433 conditions by eHealthMe.

Number of Mesna and Atrial fibrillation/flutter reports submitted per year:

Could Mesna cause Atrial fibrillation/flutter?

* Approximation only. Some reports may have incomplete information.

Do you take Mesna and have Atrial fibrillation/flutter?

Check whether Atrial fibrillation/flutter is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Atrial fibrillation/flutter and when was it recovered:

Atrial fibrillation/flutter in Mesna

Expand to all the drugs that have ingredients of mesna:

Atrial fibrillation/flutter and drugs with ingredients of mesna (120 reports)

Alternative drugs to, pros and cons of Mesna:

Mesna (8,296 reports)

Common Mesna side effects:

Browse all side effects of Mesna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Atrial fibrillation/flutter treatments and more:

Atrial fibrillation/flutter (320,306 reports)

COVID vaccines that are related to Atrial fibrillation/flutter:

Common drugs associated with Atrial fibrillation/flutter:

All the drugs that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (3,636 drugs)

Common conditions associated with Atrial fibrillation/flutter:

High blood pressure: 7,895 reports
Multiple myeloma: 5,272 reports
Rheumatoid arthritis: 5,047 reports
Diabetes: 3,939 reports

All the conditions that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (3,433 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mesna (the active ingredients of Mesna) and Mesna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.